Press Releases

Date Title and Summary Additional Formats
Toggle Summary Harvard Bioscience Reports Second Quarter 2017 Financial Results
HOLLISTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and six months ended June 30, 2017.
View HTML
Toggle Summary Harvard Bioscience Schedules Second Quarter 2017 Conference Call for July 27 at 4:30 PM ET
HOLLISTON, Mass., July 18, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2017 after market trading hours on Thursday, July 27, 2017.
View HTML
Toggle Summary Harvard Bioscience Elects James Green as Chairman of Board of Directors
HOLLISTON, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has elected James Green, a current Board member, as the new Chairman of its Board of
View HTML
Toggle Summary Harvard Bioscience Reports First Quarter 2017 Financial Results
HOLLISTON, Mass., April 27, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported its financial results for the quarter ended March 31, 2017.
View HTML
Toggle Summary Harvard Bioscience Schedules First Quarter 2017 Conference Call for April 27 at 4:30 PM ET
HOLLISTON, Mass., April 19, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2017 after market trading hours on Thursday, April 27, 2017.
View HTML
Toggle Summary Harvard Bioscience Reports Fourth Quarter and Year-End 2016 Results and 2017 Financial Guidance
HOLLISTON, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial results for the fourth quarter and full year ended December 31,
View HTML
Toggle Summary Harvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET
HOLLISTON, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2016 after market trading hours on Thursday, March 9, 2017.
View HTML
Toggle Summary Harvard Bioscience Reports Third Quarter 2016 Financial Results
Announces the Disposition of AHN Biotechnologie GmbH for $1.7 million
View HTML
Toggle Summary Harvard Bioscience Schedules Third Quarter 2016 Conference Call for October 27 at 4:30 PM ET
HOLLISTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2016 after market trading hours on Thursday, October 27, 2016.
View HTML
Toggle Summary Harvard Bioscience Reports Second Quarter 2016 Financial Results
Conference Call To Be Held at 8:30 AM ET Today
View HTML